Impact of cesarean antibiotic prophylactic protocol of in the Hospital Center Pereira Rossell
Abstract
Background: a cesarean antibiotic prophylactic protocol, was implemented in July 2002 in the Hospital Center Pereira Rossell (CHPR): intravenous administration of 2 g of cefazoline post-eclampsia.
Objectives: to assess fulfillment and impact of the protocol on antibiotic consumption and costs.
Methods: protocol was compared through individual pharmacological profile (indicated antibiotic, time and duration of administration) in November 2002 and Novembre 2004. Impact of application was compared through monthly consumption variation (DDD/100 beds days) (daily dose/days beds) and antibiotic costs (U$S) during May-November 2002 and May-November 2004. Data was collected through the analysis of distribution and administration of unit dosage, and clinical histories.
Results: protocol rates was achieved in 85% (n=41) of studied patients in 2002 and 65% (n=47) in 2004 (p<0.05). After the implementation of the protocol, a significative decrease in cefazoline consumption was observed: from 25 DDD/100 beds/day in June to 3 DDD/100 beds/day in July. During the remaining studied period, cefazoline consumption was less than 3 DDD/100 beds/day.
Conclusions: in 2002 the impact of the implementation of the protocol regarding cefazoline consumption and costs was positive; during 2004, protocol achievement decreased significantly due to an inferior administration of the protocolized dose. Further analysis on post-surgical infectious complications and adverse events need to be considered in order to assess effectiveness of the protocol. Development of therapeutic guidelines is a primary strategy to promote a rational use of drugs.
References
(2) World Health Organization. Containing anmicrobial resistance: review of the literature and report of a WHO workshop on the development of a global strategy for the containment of antimicrobial resistance. Geneva: WHO, 1999:1-54.
(3) Organización Panamericana de la Salud. Pautas o protocolos de tratamiento y guías farmacológicas. In: Quick J. ed. La gestión del suministro de medicamentos: selección, compra, distribución y utilización de productos farmacéuticos. 2 ed. Boston: Management Sciences for Health, 2002: 161-76.
(4) Girón Aguilar N, D’Alessio R. Guía para el desarrollo de los servicios farmacéuticos hospitalarios: sistema de distribución de medicamentos por dosis unitarias. (Serie Medicamentos Esenciales y Tecnología, 5). Washington: OPS/OMS, 1997: 1-45.
(5) McIntire H. Sistemas de distribución de medicamentos. In: Wertheimer A, Daniels C. Manual para la administración de farmacias hospitalarias. Washington: OPS/OMS, 1989: 147-63.
(6) Pardo Gracia C, Sagales Torra M, Oms Arias M, Mas Lombarte MP. Evaluación de la atención farmacéutica en la prescripción de medicamentos. Farm Hosp 1995; 19(3): 133-5.
(7) Capellà D, Laporte JR. Métodos aplicados en estudios descriptivos de utilización de medicamentos. In: Laporte JR, Tognoni G. Principios de epidemiología del medicamento. 2 ed. Barcelona: Masson-Salvat, 1993: 67-93.
(8) Giachetto G, Martínez A, Pírez M, Algorta G, Banchero P, Camacho C, et al. Vigilancia del uso de antibióticos en el Hospital Pediátrico del Centro Hospitalario Pereira Rossell: susceptibilidad antimicrobiana; gasto y consumo de antibióticos. Rev Méd Urug 2003; 19: 208-15.
(9) Giachetto G, Álvarez C, Arnaud H, Bruno P, Da Silva E, De Salterain H, et al. Uso de antibióticos en servicios de internación pediátrica. Rev Méd Urug 2001; 17: 55-61.
(10) Banchero P, Vázquez X, De Larrobla M, Giachetto G, Tamosiunas G, Greckzanik A. Uso de antibióticos en un servicio de internación ginecológica, Resultados preliminares. Medicam Salud 2001; 4 (1,2,3): 8-12.
(11) Laing RO, Hogerzeil HV, Ross-Degnan D. Ten recommendations to improve use of medicines in developing countries. Health policy Plan 2001; 16(1): 13-20.
(12) Hager WD, Rapp RP, Billeter M, Bradley B. Choice of antibiotic in non elective cesarean section. Antimicrob Agents Chemother 1991; 35(9): 1782-4.
(13) Wax JR, Hersey K, Philput C, Wright MS, Nichols KV, Eggleston MK, et al. Single dose of cefazolin prophylaxis for postcesarean section: before vs. after cord clamping. J Matern Fetal Med 1997; 6(1): 61-5.
(14) Rouzzi AA, Khalifa F, Baaqeel H, Al-Hamdan HS, Bondagji N. The routine use of cefazolin in cesarean section. Int J Gynaecol Obstet 2000; 69(2): 107-12.
(15) Arnau JM, Laporte JR. Promoción del uso racional de los medicamentos y preparación de guías farmacológicas. In: Laporte JR, Tognoni G. ed. Principios de epidemiología del medicamento. 2 ed. Barcelona: Masson-Salvat, 1993: 49-66.
(16) Kish MA. Guide to development of practice guidelines. Clin Infect Dis 2001; 32: 851-4.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
